Vise Technologies Inc. Invests $308,000 in Dolby Laboratories, Inc. (NYSE:DLB)

Vise Technologies Inc. purchased a new stake in shares of Dolby Laboratories, Inc. (NYSE:DLB - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,942 shares of the electronics maker's stock, valued at approximately $308,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC lifted its stake in shares of Dolby Laboratories by 10,441,900.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 104,420 shares of the electronics maker's stock worth $8,123,000 after purchasing an additional 104,419 shares during the period. Barclays PLC lifted its stake in shares of Dolby Laboratories by 80.5% in the 3rd quarter. Barclays PLC now owns 33,230 shares of the electronics maker's stock worth $2,544,000 after purchasing an additional 14,825 shares during the period. AlphaQuest LLC lifted its stake in shares of Dolby Laboratories by 111.1% in the 4th quarter. AlphaQuest LLC now owns 6,148 shares of the electronics maker's stock worth $480,000 after purchasing an additional 3,235 shares during the period. Twin Tree Management LP bought a new position in shares of Dolby Laboratories in the 4th quarter worth approximately $662,000. Finally, Raymond James Financial Inc. bought a new position in shares of Dolby Laboratories in the 4th quarter worth approximately $1,872,000. Hedge funds and other institutional investors own 58.56% of the company's stock.

Insider Activity at Dolby Laboratories

In related news, SVP John D. Couling sold 675 shares of the firm's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $75.04, for a total value of $50,652.00. Following the completion of the transaction, the senior vice president now directly owns 121,151 shares of the company's stock, valued at approximately $9,091,171.04. This trade represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 38.39% of the stock is currently owned by insiders.

Dolby Laboratories Stock Performance

DLB traded up $0.27 during trading on Thursday, reaching $74.91. 370,980 shares of the company traded hands, compared to its average volume of 452,851. Dolby Laboratories, Inc. has a 12-month low of $66.35 and a 12-month high of $89.66. The firm has a fifty day simple moving average of $75.47 and a 200 day simple moving average of $78.55. The company has a market cap of $7.20 billion, a P/E ratio of 27.54 and a beta of 0.95.

Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The electronics maker reported $1.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.29 by $0.05. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. The business had revenue of $369.56 million during the quarter, compared to analyst estimates of $375.44 million. During the same period last year, the firm posted $1.27 EPS. The company's revenue was up 1.4% on a year-over-year basis. As a group, sell-side analysts expect that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 21st. Investors of record on Tuesday, May 13th were issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date of this dividend was Tuesday, May 13th. Dolby Laboratories's dividend payout ratio (DPR) is presently 49.81%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on DLB shares. Tigress Financial started coverage on shares of Dolby Laboratories in a research note on Thursday, May 15th. They set a "buy" rating and a $112.00 target price on the stock. Rosenblatt Securities decreased their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Barrington Research restated an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, May 2nd. Finally, Wall Street Zen cut shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.